700 patients109,892 observations180 daysLIVE

DeepGene damage signature

SyntheticSynthetic demo data2 samples: baseline day 0 · retest day 90
Damage score · retest day 90
84/100
vs baseline (day 0)
+10
1 improved · 8 worsened
synthetic signature · consistent with this patient's biology
  • 3 opportunists above range: Escherichia coli, Streptococcus gallolyticus, Clostridioides difficile
  • 5 keystone species absent
  • Shannon 2.27 (expected ≥ 3)
  • 9 resistance genes
  • Host DNA fragmentation atypical
  • Tissue recycling index 56
Pathogens / opportunists3/5
from 4
Keystone species5/8
from 4
Diversity2/2
Metabolic modules1/4
Vitamin synthesis4/7
from 3
Oral translocation1/1
Host DNA1/1
from 0
Tissue recycling1/1
Central mechanisms2/2
from 1
Virulence factors5/5
from 4
Antibiotic resistance genes9/9
from 6
Genetic predisposition2/2
Opportunists above range
Escherichia coli 25.768% AR
Streptococcus gallolyticus 2.577% AR
Clostridioides difficile 2.577% AR
Keystone species absent
Akkermansia muciniphila, Bifidobacterium longum, Butyricicoccus pullicaecorum, Eubacterium rectale, Faecalibacterium prausnitzii
Capacity
Shannon 2.27 · butyrate 414 CPM · SCFA 806
H2S above band
4 vitamins below
Host & mechanisms
host DNA fragmentation atypical
tissue recycling 56/100
oral translocation 5.85% AR
molecular_mimicry above
estrobolome above
9 resistance genes · 5 virulence factors
Import a sample

A baseline sample re-initializes this patient's microbiome, pathways and predispositions from the measurement; a retest adds a comparison and updates them. Every theory, steering gain and dietary sensitivity downstream is then conditioned on the measured signature.

All elements · baseline → latest
Value, status vs the expected range, and the implication on health. Changes coloured: green improved / resolved, red worsened / new.
Pathogens / opportunists · 5
Escherichia coli20.444 % AR · above range25.768 % AR · above rangeexpected <= 1%In excess raises LPS load and zonulin release, opening tight junctions.
Klebsiella pneumoniae0.014 % AR · in range0.194 % AR · in rangeexpected <= 0.3%Opportunist above range; relevant after antibiotics and in inflammation.
Enterococcus faecium10.222 % AR · above range0.222 % AR · in range(improved)expected <= 0.5%Opportunist above range; relevant after antibiotics and in inflammation.
Streptococcus gallolyticus2.044 % AR · above range2.577 % AR · above rangeexpected <= 0.1%Opportunist above range; relevant after antibiotics and in inflammation.
Clostridioides difficile2.044 % AR · above range2.577 % AR · above rangeexpected <= 0.1%Opportunist above range; relevant after antibiotics and in inflammation.
Keystone species · 8
Akkermansia muciniphila0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Bifidobacterium longum0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Butyricicoccus pullicaecorum0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Eubacterium rectale0 % AR · absent0 % AR · absentexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Faecalibacterium prausnitzii1.32 % AR · in range0 % AR · absent(worsened)expected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Lactobacillus species0.34 % AR · in range0.63 % AR · in rangeexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Roseburia intestinalis1.31 % AR · in range1.29 % AR · in rangeexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Ruminococcus bromii0.26 % AR · in range0.36 % AR · in rangeexpected 0.15-2.24%Keystone butyrate producer / mucin specialist.
Diversity · 2
indice Shannon2.45 · below range2.27 · below rangeexpected >= 3.0Low diversity: fewer reserve metabolic routes, slower recovery after perturbation.
numar de specii detectate98 specii · below range88 specii · below rangeexpected >= 100Species count below reference.
Metabolic modules · 4
Butyrate production537 CPM · in range414 CPM · in rangeexpected 255.83-1089.91 CPMButyrate is the main colonocyte fuel and barrier signal.
Short Chain Fatty Acid Production898 CPM · in range806 CPM · in rangeexpected 535.03-1572.59 CPMTotal SCFA capacity.
GABA production311 CPM · in range244 CPM · in rangeexpected 87.31-766.53 CPMGut–brain axis capacity.
H2S production (sulfate reduction)465 CPM · above range479 CPM · above rangeexpected banda de referintaHydrogen sulfide above band irritates the mucosa.
Vitamin synthesis · 7
Vitamin B1 - Thiamin176 CPM · below range537 CPM · below rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B2 - Riboflavin165 CPM · below range341 CPM · below rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B5 - Pantothenic acid282 CPM · below range251 CPM · below rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B6 - Pyridoxine2755 CPM · in range321 CPM · below range(worsened)expected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B7 - Biotin2838 CPM · in range3905 CPM · in rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B9 - Folate3365 CPM · in range3631 CPM · in rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Vitamin B12 - Cobalamin4316 CPM · in range3796 CPM · in rangeexpected 2000-5000 CPMMicrobial synthesis capacity.
Oral translocation · 1
Translocare orala (indice)4.65 % AR · above range5.85 % AR · above rangeexpected <= 2%Oral taxa in stool: reduced gastric barrier or dysbiosis.
Host DNA · 1
fragmentare mixta156 pb · in range247 pb · atypical(worsened)expected 150-170 pbHost cell-free DNA fragmentation pattern.
Tissue recycling · 1
indice de reciclare tisulara48 /100 · above range56 /100 · above rangeexpected < 35Epithelial turnover.
Central mechanisms · 2
molecular_mimicry70 /100 · above range68 /100 · above rangeexpected < 65Cross-reactive antigen load.
estrobolome64 /100 · in range67 /100 · above range(worsened)expected < 65Estrogen-recycling capacity.
Virulence factors · 5
fimD outer membrane usher21 potriviri/M · present43 potriviri/M · presentexpected absentVirulence factor detected.
chuA heme/hemoglobin receptor46 potriviri/M · present43 potriviri/M · presentexpected absentVirulence factor detected.
irp2 yersiniabactin synthetase34 potriviri/M · present92 potriviri/M · presentexpected absentVirulence factor detected.
espX4 type III secretion46 potriviri/M · present91 potriviri/M · presentexpected absentVirulence factor detected.
kpsD polysialic acid transport77 potriviri/M · present(new)expected absentVirulence factor detected.
Antibiotic resistance genes · 9
sul11.1 citiri/M · present4.4 citiri/M · presentexpected nedetectatResistance gene detected.
sul28.7 citiri/M · present8 citiri/M · presentexpected nedetectatResistance gene detected.
tet(O/M/O)5.1 citiri/M · present1.9 citiri/M · presentexpected nedetectatResistance gene detected.
Ecol_ampC_BLA1.3 citiri/M · present9.6 citiri/M · presentexpected nedetectatResistance gene detected.
aadA10.9 citiri/M · present8.9 citiri/M · presentexpected nedetectatResistance gene detected.
dfrA12.9 citiri/M · present1.1 citiri/M · presentexpected nedetectatResistance gene detected.
APH(6)-Id3.8 citiri/M · present(new)expected nedetectatResistance gene detected.
Erm(49)10.4 citiri/M · present(new)expected nedetectatResistance gene detected.
msrC8 citiri/M · present(new)expected nedetectatResistance gene detected.
Genetic predisposition · 2
FUT22.65 OR · risk variant2.74 OR · risk variantexpected reference genotypeReduced mucosal fucosylation
CYP2D62.39 OR · risk variant1.94 OR · risk variantexpected reference genotypeExpected exposure